Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 3 EP applications Franziska Preißinger has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 16, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11716890

IMPROVED CELL CULTURE MEDIUM

IPC classification:
C12N 5/00
Applicant:
Novartis AG
Agent:
Henkel Breuer & Partner
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP11193438

Polymorph of Rilpivirine hydrochloride and its use as antiviral

IPC classification:
A61K 31/501, A61P 31/00, C07D 239/48
Applicant:
Sandoz AG
Agent:
Franziska Preißinger, Sandoz International GmbH
Status:
APPLICATION REFUSED
EP12156160

Novel crystalline form of rilpivirine hydrochloride

IPC classification:
A61K 31/505, A61P 31/18, C07D 239/48
Applicant:
Sandoz AG
Agent:
Franziska Preißinger, Sandoz International GmbH
Status:
APPLICATION REFUSED

Please Sign in to use this feature